ELLENCE Side Effects

6866669-7 | Cardiac Failure Congestive, Thrombosis
on Aug 29, 2009 Female patient from UNITED STATES , 65 years of age, weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ellence (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, thrombosis. Ellence dosage: Intravenous.

6787875-6 | Leukopenia, Pharyngitis, Pyrexia
Patient was taking Ellence (View Usage). Patient had the following side effects: leukopenia, pharyngitis, pyrexia on Oct 18, 2007 from GERMANY Additional patient health information: Female patient , 45 years of age, weighting 172.0 lb, . Ellence dosage: . During the same period patient was treated with NEUPOGEN (View Neupogen Review and Neupogen Label ), DEXAMETHASONE ACETATE (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ), NAVOBAN (View Navoban Review and Navoban Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ). Patient was hospitalized.

5713267-4 | Blister, Catheter Related Complication, Catheter Site Related Reaction, Device Dislocation, Dizziness, Dysarthria, Extravasation, Hypertrophic Scar, Muscle Injury
Adverse event was reported on Apr 11, 2008 by a Female patient taking Ellence (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , weighting 169.8 lb, After Ellence was administered, patient had the following side effects: blister, catheter related complication, catheter site related reaction, device dislocation, dizziness (What is dizziness?), dysarthria, extravasation, hypertrophic scar, muscle injury. During the same period patient was treated with FLUOROURACIL (Daily Dose:972mg) (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (Daily Dose:972mg) (View Cyclophosphamide Review and Cyclophosphamide Label ).

5711319-6 | Cardiomyopathy
on Apr 18, 2008 Female patient from UNITED STATES , weighting 167.1 lb, was treated with Ellence (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?). Ellence dosage: 185 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (925 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (925 Mg) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.


5364883-3 | Erythema, Oedema, Phlebitis
on Jan 26, 2007 Female patient from UNITED STATES , weighting 175.9 lb, was treated with Ellence (View Usage). Patient had the following side effects: erythema, oedema, phlebitis. Ellence dosage: (100 Mg/m*2, Every Day 21 Days), Intravenous. During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ALOXI (View Aloxi Review and Aloxi Label ), DECADRON (View Decadron Review and Decadron Label ).

5364881-X | Blister, Erythema, Extravasation
Patient was taking Ellence (View Usage). After Ellence was administered, patient had the following side effects: blister, erythema, extravasation on Aug 08, 2006 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 166.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ellence dosage: 75 Mg/m*2(75 Mg/m2,qd; 21 Days Cycle).

5364876-6 | Febrile Neutropenia
Adverse event was reported on Jul 10, 2006 by a Female patient taking Ellence (View Usage) (Dosage: 90 Mg (90 Mg, Interval: Every 3 Weeks), Intravenous) . Location: UNITED STATES , 58 years of age, weighting 179.0 lb, Patient experienced the following unwanted or unexpected effects: febrile neutropenia. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized.

5364874-2 | Dry Skin, Erythema, Skin Exfoliation, Swelling
on Jun 19, 2006 Female patient from UNITED STATES , 44 years of age, weighting 87.00 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ellence (View Usage). Patient had the following side effects: dry skin, erythema, skin exfoliation, swelling. Ellence dosage: 120 Mg (120 Mg), Intravenous. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

5341415-7 | Accidental Exposure, Conjunctivitis, Eye Irritation, Occupational Exposure To Toxic Agent
on May 29, 2007 Female patient from UNITED STATES , 50 years of age, weighting 160.0 lb, was treated with Ellence (View Usage). After Ellence was administered, patient had the following side effects: accidental exposure, conjunctivitis, eye irritation, occupational exposure to toxic agent. Ellence dosage: 108mg/154ml Ns Once Iv Drip.

5322690-1 | Blister, Catheter Related Complication, Catheter Site Related Reaction, Device Dislocation, Dizziness, Dysarthria, Extravasation, Muscle Injury, Nausea
Patient was taking Ellence (View Usage). Patient experienced the following unwanted or unexpected effects: blister, catheter related complication, catheter site related reaction, device dislocation, dizziness (What is dizziness?), dysarthria, extravasation, muscle injury, nausea (What is nausea?) on May 01, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 170.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ellence dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

5123188-6 | Dysphagia, Erythema, Pruritus, Throat Tightness, Urticaria
Adverse event was reported on Sep 23, 2006 by a Female patient taking Ellence (View Usage) (Dosage: 190 Mg (190 Mg, 1 In 21 D), Intravenous) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 60 years of age, weighting 181.0 lb, Patient had the following side effects: dysphagia, erythema, pruritus, throat tightness, urticaria. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), CELEXA (View Celexa Review and Celexa Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), DECADRON (View Decadron Review and Decadron Label ), ANTIEMETICS AND ANTINAUSEANS (ANTIEMETICS AND ANTINAUSEANTS) (View Antiemetics And Antinauseans (antiemetics And Antinauseants) Review and Antiemetics And Antinauseans (antiemetics And Antinauseants) Label ), PROMETHAZINE HYDROCHLORIDE TAB (View Promethazine Hydrochloride Tab Review and Promethazine Hydrochloride Tab Label ).

5092442-9 | Dysphagia, Pruritus, Throat Tightness, Urticaria
on Aug 12, 2006 Female patient from UNITED STATES , 60 years of age, weighting 181.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ellence (View Usage). After Ellence was administered, patient had the following side effects: dysphagia, pruritus, throat tightness, urticaria. Ellence dosage: 190 Mg (190 Mg, Daily Interval: Every 21 Days), Intravenous. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), CELEXA (View Celexa Review and Celexa Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), DECADRON (View Decadron Review and Decadron Label ), ANTIEMETICS AND ANTINAUSEANTS (ANTIEMETICS AND ANTINAUSEANTS) (View Antiemetics And Antinauseants (antiemetics And Antinauseants) Review and Antiemetics And Antinauseants (antiemetics And Antinauseants) Label ).

5037456-X | Hypersensitivity, Pruritus, Urticaria
on Dec 09, 2005 Female patient from UNITED STATES , 52 years of age, weighting 134.7 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ellence (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, pruritus, urticaria. Ellence dosage: 100 Mg/m2. During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

4900252-5 | Breath Sounds Abnormal, Cardiomyopathy, Ejection Fraction Decreased, Performance Status Decreased, Pericardial Disease, Pericardial Effusion, Pericarditis Constrictive, Pleural Effusion
Patient was taking Ellence (View Usage). Patient had the following side effects: breath sounds abnormal, cardiomyopathy (What is cardiomyopathy?), ejection fraction decreased, performance status decreased, pericardial disease, pericardial effusion, pericarditis constrictive, pleural effusion on Jan 19, 2006 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 226.4 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ellence dosage: 154 Mg (1 In 21 D), Intravenous. During the same period patient was treated with FLUOROURACIL (820 Mg (1 In 21 D), Intravenous) (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (820 Mg (1 In 21 D), Intravenous) (View Cyclophosphamide Review and Cyclophosphamide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

4896261-5 | Angiopathy, Breast Pain, Burning Sensation, Catheter Site Related Reaction, Caustic Injury, Chest Pain, Communication Disorder, Device Dislocation, Device Failure
Adverse event was reported on Jan 13, 2006 by a Female patient taking Ellence (View Usage) (Dosage: See Image) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 47 years of age, weighting 173.0 lb, After Ellence was administered, patient had the following side effects: angiopathy, breast pain, burning sensation, catheter site related reaction, caustic injury, chest pain (What is chest pain?), communication disorder, device dislocation, device failure. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (See I Age) (View Cyclophosphamide Review and Cyclophosphamide Label ).

4880225-1 | Pneumothorax
on Dec 29, 2005 Female patient from UNITED STATES , 51 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ellence (View Usage). Patient experienced the following unwanted or unexpected effects: pneumothorax. Ellence dosage: Cyclic. During the same period patient was treated with ALOXI (PALNOSETRON) (View Aloxi (palnosetron) Review and Aloxi (palnosetron) Label ), DECADRON (View Decadron Review and Decadron Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ).

4878049-4 | Back Pain, Muscle Spasms
on Dec 28, 2005 Female patient from UNITED STATES , 47 years of age, weighting 120.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ellence (View Usage). Patient had the following side effects: back pain (What is back pain?), muscle spasms. Ellence dosage: 100 Mg/m2 (100 Mg/m2, Cyclic Interval: Every 3 Weeks), Intravenous. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), ALOXI (PALONOSETRON) (View Aloxi (palonosetron) Review and Aloxi (palonosetron) Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

4810841-4 | Bacteria Stool Identified, Bacterial Infection, Blood Chloride Increased, Blood Creatinine Increased, Blood Phosphorus Increased, Blood Sodium Increased, Blood Urea Increased, Blood Urine Present, Candidiasis
Patient was taking Ellence (View Usage). After Ellence was administered, patient had the following side effects: bacteria stool identified, bacterial infection (What is bacterial infection?), blood chloride increased, blood creatinine increased, blood phosphorus increased, blood sodium increased, blood urea increased, blood urine present, candidiasis on Oct 11, 2005 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 252.0 lb, was diagnosed with breast cancer female, ill-defined disorder and. Ellence dosage: 160 Mg (day 1/cycle 1), Intravenous. During the same period patient was treated with DOCETAXEL (DOCETAXEL) (160 Mg (day 1/cycle 1), Intravenous) (View Docetaxel (docetaxel) Review and Docetaxel (docetaxel) Label ), DECADRON (16 Mg (qd)) (View Decadron Review and Decadron Label ), NORVASC (View Norvasc Review and Norvasc Label ), AMARYL (View Amaryl Review and Amaryl Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), GLUCOSE (GLUCOSE) (View Glucose (glucose) Review and Glucose (glucose) Label ). Patient was hospitalized.

4809871-8 | Bacterial Infection, Blood Chloride Increased, Blood Glucose Increased, Blood Phosphorus Increased, Blood Sodium Increased, Blood Urea Increased, Blood Urine, Candidiasis, Culture Stool Positive
Adverse event was reported on Oct 11, 2005 by a Female patient taking Ellence (View Usage) (Dosage: 160 Mg (day 1/cycle 1), Intravenous) was diagnosed with breast cancer female, ill-defined disorder and. Location: UNITED STATES , 63 years of age, weighting 252.0 lb, Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), blood chloride increased, blood glucose increased, blood phosphorus increased, blood sodium increased, blood urea increased, blood urine, candidiasis, culture stool positive. During the same period patient was treated with DOCETAXEL (DOCETAXEL) (160 Mg (day 1/cycle 1), Intravenous) (View Docetaxel (docetaxel) Review and Docetaxel (docetaxel) Label ), DECADRON (16 Mg (qd)) (View Decadron Review and Decadron Label ), NORVASC (View Norvasc Review and Norvasc Label ), AMARYL (View Amaryl Review and Amaryl Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), GLUCOSE (GLUCOSE) (View Glucose (glucose) Review and Glucose (glucose) Label ). Patient was hospitalized.

4807768-0 | Back Pain, Stomach Discomfort
on Oct 06, 2005 Female patient from UNITED STATES , 45 years of age, weighting 140.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ellence (View Usage). Patient had the following side effects: back pain (What is back pain?), stomach discomfort. Ellence dosage: (cyclic), Intravenous. During the same period patient was treated with CYTOXAN ((cyclic), Intravenous) (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

4807670-4 | Back Pain, Nausea
on Oct 06, 2005 Female patient from UNITED STATES , 45 years of age, weighting 140.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ellence (View Usage). After Ellence was administered, patient had the following side effects: back pain (What is back pain?), nausea (What is nausea?). Ellence dosage: (cyclic), Intravenous. During the same period patient was treated with CYTOXAN ((cyclic), Intravenous) (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

4676737-6 | Cardiac Failure Congestive, Cardiomyopathy, Electrocardiogram Q Wave Abnormal, Hypertension, Po2 Decreased
Patient was taking Ellence (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?), electrocardiogram q wave abnormal, hypertension, po2 decreased on May 20, 2005 from Additional patient health information: Female patient , 47 years of age, weighting 198.4 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ellence dosage: 75 Mg/m2 (75 Mg/m2, Cyclic, Every 21 Days), Intravenous. During the same period patient was treated with DOCETAXEL (DOCETAXEL) (75 Mg/m2 (75 Mg/m2, Cyclic, Every 21 Days), Intravenous) (View Docetaxel (docetaxel) Review and Docetaxel (docetaxel) Label ). Patient was hospitalized.

4665400-3 | Cardiac Failure Congestive, Cardiomyopathy, Condition Aggravated, Ejection Fraction Decreased, Electrocardiogram Abnormal, Hypertension, Po2 Decreased
Adverse event was reported on May 09, 2005 by a Female patient taking Ellence (View Usage) (Dosage: 75 Mg/m2 (75 Mg/m2, Cyclic, Every 21 Days), Intravenous) was diagnosed with breast cancer (What is breast cancer?) and. Location: , 47 years of age, weighting 198.4 lb, Patient had the following side effects: cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?), condition aggravated, ejection fraction decreased, electrocardiogram abnormal, hypertension, po2 decreased. During the same period patient was treated with DOCETAXEL (DOCETAXEL) (75 Mg/m2 (75 Mg/m2, Cyclic, Every 21 Days), Intravenous) (View Docetaxel (docetaxel) Review and Docetaxel (docetaxel) Label ). Patient was hospitalized.

4645756-8 | Pericardial Effusion, Pneumonitis
on Apr 12, 2005 Female patient from , 41 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ellence (View Usage). After Ellence was administered, patient had the following side effects: pericardial effusion, pneumonitis. Ellence dosage: 182 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (1260 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), EPOETIN ALFA (EPOETIN ALFA) (60000 I.u. (interval: Every Week For 3 Weeks), Subcutaneous) (View Epoetin Alfa (epoetin Alfa) Review and Epoetin Alfa (epoetin Alfa) Label ), FILGRASTIM (FILGRASTIM) (240 Mcg (interval: 12 Days), Subcutaneous) (View Filgrastim (filgrastim) Review and Filgrastim (filgrastim) Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ONDANSETRON (ONDASETRON) (View Ondansetron (ondasetron) Review and Ondansetron (ondasetron) Label ), PROCHLORPERAZINE MALEATE (View Prochlorperazine Maleate Review and Prochlorperazine Maleate Label ). Patient was hospitalized.